Physician profile
Kevin Okeefe
NPI 1780845289
$17,098.01
in general payments reported to CMS, 2019-2025
6 companies · $4,919 in 2025
The $4,919 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $359 · 2021: $3,015 · 2022: $3,786 · 2023: $1,175 · 2024: $2,999 · 2025: $4,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,295 · Travel and Lodging: $3,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,294.55 |
| Travel and Lodging | $3,798.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,873.57 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Insignia |
| Prodigy Surgical Distribution, INC. | $5,532.56 | 2021-2025 | |
| Arthrex, INC. | $5,262.35 | 2021-2025 | Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Zimmer Biomet Holdings, INC. | $182.12 | 2025 | Persona, Identity |
| Depuy Synthes Sales INC. | $171.79 | 2022-2025 | Na |
| Smith+Nephew, INC. | $75.62 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Okeefe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.